GUYER WILLIAM (Chief Development Officer) sold 83.4% of their position (20K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $1.41M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2026ACC: 0001193125-26-257618
Officer· Chief Development Officer
Since Aug 2021
-20K
Net shares
Net seller
$1.41M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
$21.65
Trade value
$433K
% of position
501.9%
6/2/2026
3.98K→23.98K
Common Stock
Direct
Shares
−20K
Price / share
$70.60
Trade value
$1.41M
% of position
83.4%
6/2/2026
23.98K→3.98K
Total
Net shares
+0.00
Net value
-$979K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2026 | M · Option Exercise | +20K | $21.65 | $433K | 501.9% | 3.98K | 23.98K |
| Common Stock Direct | 6/2/2026 | S · Sale | −20K | $70.60 | $1.41M | 83.4% | 23.98K | 3.98K |
| Total | +0.00 | -$979K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
21.65
Held after
150K
Exercisable
—
6/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock20K shares | 6/2/2026 | M · Option Exercise | −20K | 21.65 | — | 150K |